Wei Lin sold RVMD
September 16, 2025 · Form 4 insider transaction
Wei Lin sold 2,160 shares of Revolution Medicines, Inc. at $45.82 per share, a transaction worth $99.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,160
Price
$45.82
Total value
$99.0K
InsiderWei Lin
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2025
Filing dateSeptember 18, 2025
Shares owned after88,339
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on December 23, 2024 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after March 15, 2025.; Includes 58,850 restricted stock units.